CVE:SBMSirona Biochem Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Sirona Biochem Corp Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add C$0.30 +0.01 (+3.51 %) (As of 06/5/2020 04:00 PM ET) Add Compare Share Today's RangeC$0.28Now: C$0.30▼C$0.3050-Day RangeC$0.26MA: C$0.29▼C$0.3252-Week RangeC$0.18Now: C$0.30▼C$0.69Volume71,033 shsAverage Volume130,575 shsMarket CapitalizationC$66.72 millionP/E RatioN/ADividend YieldN/ABetaN/A ProfileAdvanced ChartCompetitorsInsider TradesHeadlinesSocial Media Sirona Biochem Corp. operates as a cosmetic ingredient and drug discovery company in Canada and France. The company develops programs in three areas, including diabetes, anti-inflammatories, and anti-infectives for therapeutics; anti-aging and depigmenting agents in cosmeceuticals; and biological ingredients, such as inducers and adjuvants for the biological development and preservation. It develops a sodium glucose co-transporter inhibitor for the treatment of diabetes, as well as cosmetic skin lightening agents and compounds. The company was formerly known as High Rider Capital Inc. and changed its name to Sirona Biochem Corp. in May 2009. Sirona Biochem Corp. was incorporated in 2006 and is headquartered in Vancouver, Canada.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for Sirona Biochem. Previous Next 2.3 Community Rank Outperform VotesSirona Biochem has received 38 “outperform” votes. (Add your “outperform” vote.)Underperform VotesSirona Biochem has received 43 “underperform” votes. (Add your “underperform” vote.)Community SentimentSirona Biochem has received 53.09% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Sirona Biochem and other stocks. Vote “Outperform” if you believe SBM will outperform the S&P 500 over the long term. Vote “Underperform” if you believe SBM will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldSirona Biochem does not currently pay a dividend.Dividend GrowthSirona Biochem does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Sirona Biochem insiders have not sold or bought any company stock. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Sirona Biochem is -10.54, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Sirona Biochem is -10.54, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioSirona Biochem has a P/B Ratio of 26.82. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next Analyst Opinion: 0.0Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.46 out of 5 stars Industry, Sector and Symbol Stock Exchange CVE Industry Biotechnology Sub-IndustryN/A SectorMedical Current SymbolCVE:SBM Previous Symbol CUSIPN/A CIKN/A Webwww.sironabiochem.com Phone604-641-4466Debt Debt-to-Equity Ratio49.88 Current Ratio9.64 Quick Ratio9.37Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesC$71,243.00 Price / Sales936.49 Cash FlowC$0.01 per share Price / Cash Flow20.71 Book ValueC$0.01 per share Price / Book26.82Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding Shares226,164,000Market CapC$66.72 million Next Earnings DateN/A OptionableNot Optionable TSXV:SBM Rates by TradingView Receive SBM News and Ratings via Email Sign-up to receive the latest news and ratings for SBM and its competitors with MarketBeat's FREE daily newsletter. Sirona Biochem (CVE:SBM) Frequently Asked Questions How has Sirona Biochem's stock been impacted by COVID-19 (Coronavirus)? Sirona Biochem's stock was trading at C$0.30 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, SBM shares have decreased by 1.7% and is now trading at C$0.30. View which stocks have been most impacted by Coronavirus. Has Sirona Biochem been receiving favorable news coverage? Media headlines about SBM stock have been trending extremely negative this week, InfoTrie Sentiment reports. The research group scores the sentiment of media coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Sirona Biochem earned a media sentiment score of -5.0 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an impact on the company's share price in the near future. View the latest news aboutSirona Biochem. Who are some of Sirona Biochem's key competitors? Some companies that are related to Sirona Biochem include Fennec Pharmaceuticals (FRX), Bioventix (BVXP), Ergomed (ERGO), Exicure (XCUR), Enochian Biosciences (ENOB), Theratechnologies (TH), Rafael (RFL), Pfenex (PFNX), OncoCyte (OCX), Neuren Pharmaceuticals (NEU), IMV (IMV), Horizon Discovery Group (HZD), Novacyt (NCYT), Orgenesis (ORGS) and Antibe Therapeutics (ATE). View all competitors. What other stocks do shareholders of Sirona Biochem own? Based on aggregate information from My MarketBeat watchlists, some companies that other Sirona Biochem investors own include Allena Pharmaceuticals (ALNA), Ampliphi Biosciences (APHB), Arbutus Biopharma (ABUS), Aurora Cannabis (ACBFF), AcelRx Pharmaceuticals (ACRX), Aldeyra Therapeutics (ALDX), Ampio Pharmaceuticals (AMPE), Apellis Pharmaceuticals (APLS), Aquantia (AQ) and Aquinox Pharmaceuticals (AQXP). Who are Sirona Biochem's key executives? Sirona Biochem's management team includes the following people: Dr. Howard J. Verrico M.D., Founder, Chairman, CEO & Sec. (Age 58)Mr. Christopher D. Hopton C.G.A., CFO & Director (Age 53)Dr. Géraldine Deliencourt-Godefroy Ph.D., Chief Scientific Officer & DirectorMs. Michelle Seltenrich MBA, VP of OperationsDr. Brett A. Premack Ph.D., Scientific Consultant What is Sirona Biochem's stock symbol? Sirona Biochem trades on the Canadian Venture Exchange (CVE) under the ticker symbol "SBM." How do I buy shares of Sirona Biochem? Shares of SBM and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade, and Charles Schwab. What is Sirona Biochem's stock price today? One share of SBM stock can currently be purchased for approximately C$0.30. How big of a company is Sirona Biochem? Sirona Biochem has a market capitalization of C$66.72 million and generates C$71,243.00 in revenue each year. What is Sirona Biochem's official website? The official website for Sirona Biochem is www.sironabiochem.com. How can I contact Sirona Biochem? The company can be reached via phone at 604-641-4466. This page was last updated on 6/5/2020 by MarketBeat.com Staff
